Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locally Advanced Rectal Adenocarcinoma × sotigalimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neoplasms 1 Melanoma 1 Locally Advanced Rectal Adenocarcinoma 1 Liposarcoma 1 Leiomyosarcoma 1

Interventions

sotigalimab 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04130854 2026-01-28

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

University of Texas Southwestern Medical Center

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡